Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Chirurgie Cardiovasculaire et Thoracique Dr Michel Buche from Profondeville, company number BE0675735949, closed financial year 2025 with a result of € 244,703 after tax. For that financial year Chirurgie Cardiovasculaire et Thoracique Dr Michel Buche recorded a gross margin of € 356,257 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 211,313 to € 244,703. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 1.5 million
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 244,703
▲ 16% vs 2024
Profit after tax over the fiscal year.
€ 257,106
▲ 123% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.5 million.
People and assets in 2025
€ 22,776
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,415
▲ 68% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,446
▲ € 18,558 vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 309,921 | € 291,719 | € 311,008 | € 356,257 | ▲ 15% |
| Profit after taxes | € 207,562 | € 194,979 | € 211,313 | € 244,703 | ▲ 16% |
| Equity | € 819,146 | € 1,014,124 | € 1,225,438 | € 1,470,141 | ▲ 20% |
| Total debts | € 51,918 | € 2,411 | € 4,754 | € 26,981 | ▲ € 22,227 |
| Cash | € 724,358 | € 861,399 | € 115,229 | € 257,106 | ▲ 123% |
| Retained profit | € 806,746 | € 999,864 | € 1,211,178 | € 1,455,881 | ▲ 20% |
| Balance sheet total | € 871,064 | € 1,016,536 | € 1,230,191 | € 1,497,122 | ▲ 22% |
Key figures of Chirurgie Cardiovasculaire et Thoracique Dr Michel Buche, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Chirurgie Cardiovasculaire et Thoracique Dr Michel Buche?
What happened at Chirurgie Cardiovasculaire et Thoracique Dr Michel Buche in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 244,703 (▲ 16% vs 2024). Source: NBB ↗
- New establishment in Namur. KBO
- Start of the company according to the CBE. KBO
In short
From € 207,562 profit in 2022 to € 244,703 profit in 2025.
Paid € 386,515 in corporate taxes since 2022.
Best year ever: 2025, with € 244,703 profit.
Management
Behind Chirurgie Cardiovasculaire et Thoracique Dr Michel Buche is Michel Buche.
Directors
According to the 2025 annual accounts
Michel Buche
Director
Establishments
Establishment units
Physical locations of this company
Rue Frappe Cul(LU) 14
5170 Profondeville
Rue Saint-Luc(BU) 8
5004 Namur
Active since 16 May 2017
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0675.735.949
- VAT number
- BE 0675.735.949
- Registered office
- Rue Frappe Cul(LU) 14, 5170 Profondeville
- Names & denominations
- Chirurgie Cardiovasculaire et Thoracique Dr Michel Buche · ChirBu
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 May 2017
- Peppol
- Not registered